Discriminant function analysis showed higher levels of α-synuclein in the cerebrospinal fluid of asymptomatic LRRK2 mutation carriers, differentiating them from healthy and symptomatic PD controls [45]. This evidence concerns the gene SNCA and Parkinson disease.